Fungal Peritonitis Due to Gastroduodenal Perforation: Diagnostic and Treatment Challenges

1. Bassetti M, Righi E, Ansaldi F et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41(9):1601-1610.10.1007/s00134-015-3866-226077063Search in Google Scholar

2. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care. 2007;13(2):195-199.10.1097/MCC.0b013e328028fd9217327742Search in Google Scholar

3. Montravers P, Mira JP, Gangneux JP et al. AmarCand study group. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive care units. Clin Microbiol Infect. 2011;17(7):1061-1067.10.1111/j.1469-0691.2010.03360.x20825438Search in Google Scholar

4. Sandven P, Qvist H, Skovlund E, Giercksky KE. NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002;30(3):541-547.10.1097/00003246-200203000-0000811990912Search in Google Scholar

5. Dupont H, Paugam-Burtz C, Muller-Serieys C et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg. 2002;137(12):1341-1346; discussion 1347.10.1001/archsurg.137.12.134112470095Search in Google Scholar

6. Leroy O, Gangneux JP, Montravers P et al. AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009;37(5):1612-1618.10.1097/CCM.0b013e31819efac019325476Search in Google Scholar

7. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America. 2016;62(4):e1-e50.10.1093/cid/civ933472538526679628Search in Google Scholar

8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-163.10.1128/CMR.00029-06179763717223626Search in Google Scholar

9. Playford EG, Marriott D, Nguyen Q et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med. 2008;36(7):2034-2039.10.1097/CCM.0b013e3181760f4218552700Search in Google Scholar

10. Kollef M, Micek S, Hampton N et al. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54(12):1739-1746.10.1093/cid/cis30522423135Search in Google Scholar

11. Vergidis P, Clancy CJ, Shields RK et al. IntraAbdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment. PLoS One. 2016;11(4): e0153247.10.1371/journal.pone.0153247Search in Google Scholar

12. Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65(12):1611-1620.10.2165/00003495-200565120-00002Search in Google Scholar

13. Islam S, Zaidi A, Wilson J. Peritoneal Infection with Multiple Species of Candida: A Case Report. Surgical Infections. 2002;3(1):35-37.10.1089/109629602753681140Search in Google Scholar

14. Schulze J, Sonnenborn U. Yeasts in the Gut: From Commensals to Infectious Agents. Dtsch Arztebl Int. 2009;106(51-52):837-842.Search in Google Scholar

15. Mathews HL, Witek-Janusek L. Host defense against oral, esophageal, and gastrointestinal candidiasis. In: Calderone RA (ed.): Candida and candidiasis. Washington: ASM Press 2002;179-192.Search in Google Scholar

16. De Ruiter J, Weel J, Manusama E et al. The epidemiology of intraabdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009;37:522-527.10.1007/s15010-009-8249-6Search in Google Scholar

17. Dupont H, Bourichon A, Paugam-Burtz C et al. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med. 2003;31(3):752-757.10.1097/01.CCM.0000053525.49267.77Search in Google Scholar

18. Lee SC, Fung CP, Chen HY et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis. 2002;44(1):23-27.10.1016/S0732-8893(02)00419-4Search in Google Scholar

19. Tortorano AM, Peman J, Bernhardt H et al. ECMM Working Group on Candidaemia. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis. 2004;23(4):317-322.10.1007/s10096-004-1103-y15029512Search in Google Scholar

20. Carneiro HA, Mavrakis A, Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg. 2011;35(12):2650-2659.10.1007/s00268-011-1305-221976010Search in Google Scholar

21. Cornely OA, Bassetti M, Calandra T et al. ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: nonneutropenic adult patients. Clin Microbiol Infect. 2012;18 Suppl 7:19-37.10.1111/1469-0691.1203923137135Search in Google Scholar

22. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133-164.10.1086/64955420034345Search in Google Scholar

23. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis. 2007;7:103.10.1186/1471-2334-7-103207551317784947Search in Google Scholar

24. Azuhata T, Kinoshita K, Kawano D et al. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care. 2014;18(3):R87.10.1186/cc13854405711724886954Search in Google Scholar

25. Blot S, De Wele JJ, Vogelers D. Essentials for selecting antimicrobial therapy for intraabdominal infections. Drugs. 2012;72:e17-32.10.2165/11599800-000000000-00000358577022480338Search in Google Scholar

26. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother. 2007;60(3):613-618.10.1093/jac/dkm21217576697Search in Google Scholar